Nanne Kleefstra

Summary

Affiliation: Isala Klinieken

Publications

  1. ncbi request reprint [Cinnamon: not suitable for the treatment of diabetes mellitus]
    N Kleefstra
    Isala Klinieken, Diabetes Kenniscentrum, Zwolle
    Ned Tijdschr Geneeskd 151:2833-7. 2007
  2. ncbi request reprint Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4)
    Nanne Kleefstra
    Diabetes Centre, Isala Clinics, Zwolle, Netherlands
    Diabetes Care 31:932-3. 2008
  3. ncbi request reprint [New blood glucose-lowering drugs in type 2 diabetes: a review of the literature]
    Nanne Kleefstra
    Isala Klinieken, Diabetes Kenniscentrum, Zwolle, The Netherlands
    Ned Tijdschr Geneeskd 154:A886. 2010
  4. pmc Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
    Nanne Kleefstra
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Diabetes Metab Syndr Obes 2:155-63. 2009
  5. ncbi request reprint [Chromium and insulin resistance]
    N Kleefstra
    Isala Klinieken, locatie Weezenlanden, afd Interne Geneeskunde, Postbus 10 500, 8000 GM Zwolle
    Ned Tijdschr Geneeskd 148:217-20. 2004
  6. ncbi request reprint [Measuring the blood pressure in both arms is of little use; longitudinal study into blood pressure differences between both arms and its reproducibility in patients with diabetes mellitus type 2]
    N Kleefstra
    Isala Klinieken, afd Inwendige Geneeskunde, Zwolle
    Ned Tijdschr Geneeskd 151:1509-14. 2007
  7. ncbi request reprint Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled trial
    Nanne Kleefstra
    Diabetes Centre, Isala Clinics, P O Box 10400, 8000 GK Zwolle, The Netherlands
    Diabetes Care 30:1092-6. 2007
  8. ncbi request reprint Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial
    Nanne Kleefstra
    Department of Internal Medicine, Isala Clinics, Weezenlanden Location, P O Box 10500, 8000 GM Zwolle, Netherlands
    Diabetes Care 29:521-5. 2006
  9. ncbi request reprint Self-monitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC)
    N Kleefstra
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Neth J Med 68:311-6. 2010
  10. ncbi request reprint Cross-sectional relationship between glycaemic control, hyperglycaemic symptoms and quality of life in type 2 diabetes (ZODIAC-2)
    N Kleefstra
    Department of Internal Medicine, Isala Clinics, Weezenlanden Location, Zwolle, The Netherlands
    Neth J Med 63:215-21. 2005

Detail Information

Publications55

  1. ncbi request reprint [Cinnamon: not suitable for the treatment of diabetes mellitus]
    N Kleefstra
    Isala Klinieken, Diabetes Kenniscentrum, Zwolle
    Ned Tijdschr Geneeskd 151:2833-7. 2007
    ..To identify published studies evaluating the effects of cinnamon on glycaemic control...
  2. ncbi request reprint Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4)
    Nanne Kleefstra
    Diabetes Centre, Isala Clinics, Zwolle, Netherlands
    Diabetes Care 31:932-3. 2008
    ..To investigate the relationship between health-related quality of life (HRQOL) and mortality in type 2 diabetes...
  3. ncbi request reprint [New blood glucose-lowering drugs in type 2 diabetes: a review of the literature]
    Nanne Kleefstra
    Isala Klinieken, Diabetes Kenniscentrum, Zwolle, The Netherlands
    Ned Tijdschr Geneeskd 154:A886. 2010
    ....
  4. pmc Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
    Nanne Kleefstra
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Diabetes Metab Syndr Obes 2:155-63. 2009
    ..The effectiveness of self-monitoring of blood glucose (SMBG) in noninsulin-treated patients with type 2 diabetes (T2DM) remains unclear. We aimed to review the trials investigating the effects of SMBG in this population...
  5. ncbi request reprint [Chromium and insulin resistance]
    N Kleefstra
    Isala Klinieken, locatie Weezenlanden, afd Interne Geneeskunde, Postbus 10 500, 8000 GM Zwolle
    Ned Tijdschr Geneeskd 148:217-20. 2004
    ..One should be aware that individual patients with type-2 diabetes mellitus may have an increased risk of hypoglycaemic episodes when taking chromium supplements as self-medication...
  6. ncbi request reprint [Measuring the blood pressure in both arms is of little use; longitudinal study into blood pressure differences between both arms and its reproducibility in patients with diabetes mellitus type 2]
    N Kleefstra
    Isala Klinieken, afd Inwendige Geneeskunde, Zwolle
    Ned Tijdschr Geneeskd 151:1509-14. 2007
    ..To determine the prevalence of inter-arm blood pressure differences > 10 mmHg in patients with diabetes mellitus type 2 (DM2) and to determine whether these differences are consistent over time...
  7. ncbi request reprint Chromium treatment has no effect in patients with type 2 diabetes in a Western population: a randomized, double-blind, placebo-controlled trial
    Nanne Kleefstra
    Diabetes Centre, Isala Clinics, P O Box 10400, 8000 GK Zwolle, The Netherlands
    Diabetes Care 30:1092-6. 2007
    ..The aim of this study was to determine the effect of chromium treatment in the form of chromium yeast on glycemic control in a Western population of patients with type 2 diabetes who were being treated with oral hypoglycemic agents...
  8. ncbi request reprint Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial
    Nanne Kleefstra
    Department of Internal Medicine, Isala Clinics, Weezenlanden Location, P O Box 10500, 8000 GM Zwolle, Netherlands
    Diabetes Care 29:521-5. 2006
    ..The aim of this study was to determine the effect of chromium treatment on glycemic control in a Western population of insulin-dependent patients with type 2 diabetes...
  9. ncbi request reprint Self-monitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC)
    N Kleefstra
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Neth J Med 68:311-6. 2010
    ..Our aim was to investigate the effects of SMBG in patients with T2DM who were in persistent moderate glycaemic control whilst not using insulin...
  10. ncbi request reprint Cross-sectional relationship between glycaemic control, hyperglycaemic symptoms and quality of life in type 2 diabetes (ZODIAC-2)
    N Kleefstra
    Department of Internal Medicine, Isala Clinics, Weezenlanden Location, Zwolle, The Netherlands
    Neth J Med 63:215-21. 2005
    ..To describe the relationship between glycaemic control, hyperglycaemic symptoms and quality of life (HRQOL) in type 2 diabetic patients...
  11. ncbi request reprint Chronic kidney disease and mortality risk among older patients with type 2 diabetes mellitus (ZODIAC-24)
    Iefke Drion
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Age Ageing 41:345-50. 2012
    ..to investigate the association between a decreased estimated glomerular filtration rate (eGFR), albuminuria and mortality in elderly patients with type 2 diabetes mellitus (T2DM)...
  12. pmc Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16
    Gijs W D Landman
    Internal Medicine, Isala Clinics, Zwolle, The Netherlands
    Diabetes Care 33:322-6. 2010
    ..Several studies have suggested an association between specific diabetes treatment and cancer mortality. We studied the association between metformin use and cancer mortality in a prospectively followed cohort...
  13. pmc Association between 9p21 genetic variants and mortality risk in a prospective cohort of patients with type 2 diabetes (ZODIAC-15)
    Gijs W D Landman
    Diabetes Center, Isala Clinics, PO Box 10400, 8000 GK, Zwolle, The Netherlands
    Cardiovasc Diabetol 11:138. 2012
    ..The T2D SNP was inversely associated with mortality, while the CVD SNP increased the risk for mortality. We confirmed a possible, although different, synergistic relationship between HbA1c and rs2383206 on total mortality...
  14. pmc Health-related quality of life, treatment satisfaction, and costs associated with intraperitoneal versus subcutaneous insulin administration in type 1 diabetes: a randomized controlled trial
    Susan J Logtenberg
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Diabetes Care 33:1169-72. 2010
    ..To investigate the effects of continuous intraperitoneal insulin infusion (CIPII) compared with subcutaneous insulin on health-related quality of life (HRQOL) and treatment satisfaction, and to perform a cost analysis in type 1 diabetes...
  15. pmc The midregional fragment of pro-A-type natriuretic peptide, blood pressure, and mortality in a prospective cohort study of patients with type 2 diabetes (ZODIAC-25)
    Kornelis J J van Hateren
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Diabetes Care 36:1347-52. 2013
    ..Therefore, we aimed to investigate the capabilities of MR-proANP in predicting mortality. We also investigated whether MR-proANP influences the relationship between blood pressure and mortality in old age...
  16. pmc Plasma COOH-terminal proendothelin-1: a marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? (ZODIAC-29)
    Iefke Drion
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Diabetes Care 35:2354-8. 2012
    ..The aim of this study was to investigate the association between plasma COOH-terminal proendothelin-1 (CT-proET-1) and fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in patients with type 2 diabetes...
  17. doi request reprint The Cockcroft-Gault: a better predictor of renal function in an overweight and obese diabetic population
    Iefke Drion
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Obes Facts 4:393-9. 2011
    ..The performance of the Cockcroft-Gault (CG) equation, the Modification of Diet in Renal Disease (MDRD) formula, and the Chronic Kidney Disease Epidemiology Collaboration equation (CKD-EPI) was evaluated in body mass index (BMI) categories...
  18. ncbi request reprint Lower blood pressure associated with higher mortality in elderly diabetic patients (ZODIAC-12)
    Kornelis J J van Hateren
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Age Ageing 39:603-9. 2010
    ..to investigate the relationship between blood pressure over time and mortality in elderly patients with type 2 diabetes mellitus (T2DM)...
  19. pmc Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes: a randomized controlled trial
    Susan J Logtenberg
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Diabetes Care 32:1372-7. 2009
    ..CONCLUSIONS Although we did not observe a significant reduction in hypoglycemic events, improved glycemic control was achieved with the use of CIPII. We saw a 0.8% decrease in A1C and an 11% increase in the time spent in euglycemia...
  20. doi request reprint Effect of device-guided breathing exercises on blood pressure in patients with hypertension: a randomized controlled trial
    Mariette R Altena
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Blood Press 18:273-9. 2009
    ..Despite considerable efforts, it is sometimes hard to reach treatment goals for blood pressure (BP) with classical treatment options. Reducing breathing frequency has been advocated as a method to reduce BP...
  21. pmc Orthostatic hypotension, diabetes, and falling in older patients: a cross-sectional study
    Kornelis J J van Hateren
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Br J Gen Pract 62:e696-702. 2012
    ..Although orthostatic hypotension (OH) is more prevalent in old age, and in patients with diabetes, the prevalence of OH in older patients with type 2 diabetes mellitus is unknown...
  22. ncbi request reprint Device-guided breathing as treatment for hypertension in type 2 diabetes mellitus: a randomized, double-blind, sham-controlled trial
    Gijs W D Landman
    Diabetes Centre, Isala Clinics, The Netherlands University Medical Center, Zwolle, The Netherlands
    JAMA Intern Med 173:1346-50. 2013
    ..Biofeedback with device-guided lowering of breathing frequency could be an alternate nonpharmacologic treatment option for hypertension. Evidence from trials with high methodologic quality is lacking...
  23. pmc Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathy
    Alaa Alkhalaf
    Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    PLoS ONE 7:e40427. 2012
    ..We investigated the effect of benfotiamine on markers of these pathways in patients with type 2 diabetes and nephropathy...
  24. ncbi request reprint [SGLT-2 inhibitors: diabetes treatment by glycosuria; literature review on the effect of dapagliflozin]
    Nanne Kleefstra
    Isala Klinieken, Diabetes Kenniscentrum, Zwolle
    Ned Tijdschr Geneeskd 157:A5969. 2013
    ..To describe the efficacy and safety of dapagliflozin, the first sodium-glucose co-transporter-2 (SGLT-2) inhibitor for the treatment of diabetes mellitus type 2 (DM2) to be registered in the Netherlands...
  25. pmc Serum peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2 diabetes (ZODIAC-28)
    Esther G Gerrits
    Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    PLoS ONE 9:e89719. 2014
    ..The aim of this study was to investigate peroxiredoxin 4 (Prx4), a proposed novel biomarker of oxidative stress, and its association with and capability as a biomarker in predicting (cardiovascular) mortality in type 2 diabetes mellitus...
  26. doi request reprint Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events
    Kornelis J J van Hateren
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Clin Chem 58:293-7. 2012
    ..We compared the capabilities of MR-proANP and NT-proBNP for predicting mortality and cardiovascular events in a population-based study...
  27. pmc The lipid profile and mortality risk in elderly type 2 diabetic patients: a ten-year follow-up study (ZODIAC-13)
    Kornelis J J van Hateren
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    PLoS ONE 4:e8464. 2009
    ..The aim of this study was to investigate the relationship between the lipid profile over time, and mortality in elderly patients with T2DM...
  28. pmc The relationship between glycaemic control and mortality in patients with type 2 diabetes in general practice (ZODIAC-11)
    Gijs W Landman
    Internal Medicine and Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Br J Gen Pract 60:172-5. 2010
    ..The relationship between the degree of glycaemic control and mortality remains an important topic of discussion...
  29. pmc Self-monitoring of blood glucose: the use of the first or the second drop of blood
    Johanna Hortensius
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Diabetes Care 34:556-60. 2011
    ..This study investigated whether capillary glucose concentrations, as measured in the first and second drops of blood, differed ≥ 10% compared with a control glucose concentration in different situations...
  30. pmc Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trials
    Gijs W D Landman
    Diabetes Centre Zwolle, Zwolle, The Netherlands
    PLoS ONE 9:e82880. 2014
    ..The aim of this study was to assess in a systematic review and meta-analysis of randomized controlled trials the safety and efficacy of gliclazide compared to other oral glucose-lowering agents (PROSPERO2013:CRD42013004156)...
  31. pmc Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniques
    Iefke Drion
    Diabetes Centre, Isala Clinics, P O Box 10400, 8000, GK Zwolle, The Netherlands
    BMC Nephrol 13:133. 2012
    ..Non-equivalence in serum creatinine (SCr) measurements across Dutch laboratories and the consequences hereof on chronic kidney disease (CKD) staging were examined...
  32. doi request reprint Surgical aspects and complications of continuous intraperitoneal insulin infusion with an implantable pump
    Jan Willem Haveman
    Department of Surgery, Isala Clinics, P O Box 10400, 8000 GK, Zwolle, The Netherlands
    Langenbecks Arch Surg 395:65-71. 2010
    ..Continuous intraperitoneal insulin infusion (CIPII) with an implantable pump is safe and effective in selected subjects with diabetes. Our aim was to assess surgical experience and complications with CIPII...
  33. doi request reprint Pre- and postoperative accuracy and safety of a real-time continuous glucose monitoring system in cardiac surgical patients: a randomized pilot study
    Susan J Logtenberg
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Diabetes Technol Ther 11:31-7. 2009
    ....
  34. pmc Health-related quality of life and mortality in a general and elderly population of patients with type 2 diabetes (ZODIAC-18)
    Gijs W D Landman
    Diabetes Centre, Department of Internal Medicine, Isala Clinics, Zwolle, Overijssel, The Netherlands
    Diabetes Care 33:2378-82. 2010
    ..We studied the association between HRQOL and total and cardiovascular mortality in patients with type 2 diabetes during long-term follow-up and specifically focused on old age and sex differences...
  35. ncbi request reprint [Metformin in adolescents and adults with type 1 diabetes mellitus: not evidence-based]
    E A J M Angelien Spaans
    Isala Klinieken, Diabetescentrum, Zwolle, The Netherlands
    Ned Tijdschr Geneeskd 155:A3166. 2011
    ..We investigated whether there is evidence of the beneficial effect of the addition of metformin to insulin therapy in adolescents with DM1...
  36. doi request reprint Use of short-term real-time continuous glucose monitoring in type 1 diabetes patients on continuous intraperitoneal insulin infusion: a feasibility study
    Susan J J Logtenberg
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Diabetes Technol Ther 11:293-9. 2009
    ..The objective of this study is to investigate effectiveness and safety of RT-CGM in patients treated with intraperitoneal insulin through an implanted pump...
  37. ncbi request reprint Effect of device-guided breathing exercises on blood pressure in hypertensive patients with type 2 diabetes mellitus: a randomized controlled trial
    Susan J Logtenberg
    Department of Internal Medicine, Diabetes Outpatient Clinics, Isala Clinics, Zwolle, The Netherlands
    J Hypertens 25:241-6. 2007
    ..Our secondary objective was to study the effect of this device on quality of life (QOL)...
  38. ncbi request reprint [Employing age-related cut-off values results in fewer patients with renal impairment in secondary care]
    Iefke Drion
    Isala Klinieken, Zwolle, The Netherlands
    Ned Tijdschr Geneeskd 155:A3091. 2011
    ....
  39. pmc Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up
    Peter R van Dijk
    Diabetes Centre, Isala, P, O, Box 10400, 8000G, K Zwolle, The Netherlands
    BMC Endocr Disord 14:30. 2014
    ..Aim of the present study was to describe the long-term course of glycaemic control, complications, health related quality of life (HRQOL) and treatment satisfaction among T1DM patients treated with CIPII...
  40. pmc Perspectives of patients with type 1 or insulin-treated type 2 diabetes on self-monitoring of blood glucose: a qualitative study
    Johanna Hortensius
    Diabetes Centre, Isala Clinics, GK Zwolle, The Netherlands
    BMC Public Health 12:167. 2012
    ..This study investigates patients' perspectives of SMBG and all relevant aspects influencing SMBG in patients with type 1 and insulin-treated type 2 diabetes...
  41. pmc A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy
    Alaa Alkhalaf
    Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands
    Diabetes Care 33:1598-601. 2010
    ..To investigate the effect of benfotiamine on urinary albumin excretion (UAE) and the tubular damage marker kidney injury molecule-1 (KIM-1) in patients with type 2 diabetes and nephropathy...
  42. doi request reprint Can diabetes management be safely transferred to practice nurses in a primary care setting? A randomised controlled trial
    Sebastiaan T Houweling
    Diabetes Centre, Isala Clinics, Langerhans Medical Research Foundation, Zwolle, The Netherlands
    J Clin Nurs 20:1264-72. 2011
    ..To determine whether the management of type 2 diabetes mellitus in a primary care setting can be safely transferred to practice nurses...
  43. doi request reprint Self-monitoring of blood glucose: professional advice and daily practice of patients with diabetes
    Johanna Hortensius
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Diabetes Educ 38:101-7. 2012
    ..A self-reported questionnaire with 20 questions about performing SMBG was filled out by 111 patients from an outpatient diabetes clinic of a Dutch hospital...
  44. ncbi request reprint Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications
    Esther G Gerrits
    Diabetes Centre, Isala Clinics, Zwolle, P O Box 10400, 8000 GK Zwolle, Netherlands
    Diabetes Care 31:517-21. 2008
    ..Our aim was to investigate the predictive value of skin autofluorescence for the development of microvascular complications in type 2 diabetes...
  45. ncbi request reprint [Diagnosis of diabetes mellitus: limited use for portable blood-glucose measuring devices]
    S T Houweling
    afd Interne Geneeskunde, Isala Klinieken, Postbus 10 500, 8000 GM Zwolle
    Ned Tijdschr Geneeskd 149:694-7. 2005
    ..Portable blood-glucose devices should not be used as a diagnostic tool for diabetes mellitus. These should only be used for blood-glucose control monitoring during treatment or as a screening tool...
  46. ncbi request reprint Pitfalls in blood pressure measurement in daily practice
    S T Houweling
    Department of Internal Medicine, University of Groningen, Groningen, The Netherlands
    Fam Pract 23:20-7. 2006
    ..However, there is considerable variation in the different BP measuring methods suggested in guidelines and used in hypertension trials...
  47. ncbi request reprint [Use of stairs in a hospital increased by a sign near the stairs or the elevator]
    S T Houweling
    Isala Klinieken, locatie Weezenlanden, afd Interne Geneeskunde, Zwolle
    Ned Tijdschr Geneeskd 149:2900-3. 2005
    ..To investigate whether signs encouraging taking the stairs or discouraging taking the elevator lead to an increasing number of patients taking the stairs instead of the elevator in a hospital...
  48. ncbi request reprint [Employing age-related cut-off values results in fewer patients with renal impairment in secondary care]
    Iefke Drion
    Isala Klinieken, Zwolle, Diabetes Kenniscentrum, The Netherlands
    Ned Tijdschr Geneeskd 155:A3091. 2011
    ....
  49. ncbi request reprint Intensification of therapy and no increase in body mass index with longer disease duration in type 2 diabetes mellitus (ZODIAC-5)
    S J J Logtenberg
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Fam Pract 24:529-31. 2007
    ..Secondary treatment failure is often attributed to the development of obesity-related insulin resistance in combination with continued loss of beta-cell function...
  50. ncbi request reprint Increased cancer mortality in type 2 diabetes (ZODIAC-3)
    G W D Landman
    Diabetes Centre, Isala Clinics, Zwolle, The Netherlands
    Anticancer Res 28:1373-5. 2008
    ..It is unclear whether there is a relationship between type two diabetes and cancer mortality. It also is unclear whether obesity and body mass index (BMI) are associated with cancer in type 2 diabetes patients...
  51. ncbi request reprint Modification of diet in renal disease and Cockcroft-Gault formulas do not predict mortality (ZODIAC-6)
    H J G Bilo
    Diabetes Centre, Isala Clinics, P O Box 10400, 8000 G K, Zwolle, The Netherlands
    Diabet Med 26:478-82. 2009
    ..We investigated whether these formulas predict mortality better than the variables they contain together in patients with Type 2 diabetes...
  52. ncbi request reprint The relationship between obesity and cancer mortality in type 2 diabetes: a ten-year follow-up study (ZODIAC-21)
    G W Landman
    Diabetes Research Centre, Isala Clinics, PO Box 10400, 8000 GK Zwolle, The Netherlands
    Anticancer Res 30:681-2. 2010
    ..The aim of the new analyses was to investigate the same relationship after increasing our sample size and extending our follow-up period...
  53. doi request reprint Prognostic significance of between-arm blood pressure differences: between-arm blood pressure difference and mortality
    Nanne Kleefstra
    Hypertension 52:e14; author reply e16-7. 2008
  54. ncbi request reprint Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials
    Nanne Kleefstra
    Diabetes Care 30:e102; author reply e103. 2007
  55. ncbi request reprint Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: response to Welschen et al
    Nanne Kleefstra
    Diabetes Care 28:2596; author reply 2597-8. 2005